According to Custom Market Insights (CMI), The Global Antithrombin Market Size was valued at USD 502.4 million in 2021 and is estimated to reach USD 735.12 million by the end of 2030 at a CAGR of approximately 4.8% during the forecast period 2022-2030.
This component of the blood is a form of protein that helps maintain the viscosity of the blood by not allowing it to clot excessively. It mainly sees its use during surgical procedures where a heavy amount of blood is lost and proves to be fatal for the life of certain individual disorders within the body of the person or congenital causes lead to the deficiency of this blood component which hampers the viscosity of the blood and leads to excessive bleeding.
The huge number of surgical procedures that are carried out worldwide have demanded better products and alternatives that can reduce the number of casualties that occur within the operation units about this cause. Antithrombin helps to Prevent the clotting of blood and maintain the blood flow within the blood vessels of the individual.
Browse the full “Antithrombin Market Size, Trends and Insights By Application Type (Research, Therapeutics, Diagnostics), By Source (Goat milk, Human ), By Dosage (Liquid, Lyophilized), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2023–2032” report at https://www.custommarketinsights.com/report/antithrombin-market/
Market Dynamics
Drivers
The huge number of operative procedures that take place worldwide has helped boost the antithrombin market’s economy to a great extent. People suffering from blood clotting disorders need to be managed with the help of antithrombin, which facilitates a uniform viscosity of the blood and provides constant blood flow within the individual’s body. The complications arising during a surgical procedure can be managed with the help of this protein that maintains the blood flow in the body. The pandemic outbreak had a significant impact on the market growth owing to the complication of clotting of blood which seemed to be created in the body of the individuals suffering from the infection. The initiative taken up by the government to accelerate the facilities that are provided by the health care sector has attracted potential consumers to opt for better services and facilities.
Restraints
The rules and regulations imposed by the government regarding the use and application of various drugs in the healthcare sector have emerged as restraining factors for the growth of the market. Lack of awareness among the people regarding the available facilities and rapid advancements that have taken place in the health care system make them averse to advanced operative procedures. The fluctuating reimbursement facilities in the market hamper the growth of this sector to a great extent, resulting from the lack of this able income available to the people. These multiple reasons emerged as the restraining factors for the growth of the antithrombin market during the forecast period.
Opportunities
A huge number of people all over the world suffer from acquired antithrombin deficiencies which result from severe diseases in the body. Increasing awareness regarding the available advanced health care facilities and systems, which provide a better success rate for operative procedures, has encouraged people to opt for such systems. The key market players carry out constant research and development programs to introduce advanced medicines and systems into the market have helped the antithrombin market record considerable revenue over time. The huge number of high-velocity accidents that take place all over the world resulting from rapid modernization has supported the market to a great extent.
Challenges
The occurrence of various anaphylactic reactions in an individual’s body from certain externally induced protein factors or blood components emerges as a major challenge for the market’s growth. Increasing sensitivity among the people has boosted the number of casualties caused due to reactions during operative procedures. The higher cost associated with using advanced procedures and techniques during an operative procedure hinders the market’s growth to a great extent. These multiple reasons emerge as challenges to the growth of the market.
Report Highlights
Based on application, the therapeutics segment has emerged as the largest market for antithrombin due to its huge demand in this sector for operative procedures involving heavy clotting complications. Based on the source, the segment of goat milk has emerged as the leading market player. Based on dosage, the lyophilized segment has emerged as the market leader due to its extensive usage. Based on geography, the region of Asia Pacific has become the largest consumer due to the huge number of operative procedures carried out.
Regional Snapshots
The geographical region of Asia Pacific has emerged as the largest market for the antithrombin component. The huge number of operative procedures carried out in this sector has demanded better products over time. With rapid advancements in the healthcare sector with the help of the government and private organizations, the need for advanced antithrombin components has increased in the market.
The huge number of high-velocity accidents that have taken place all over the world has also boosted the demand for antithrombin to a great extent. Rapid advancements that have taken place worldwide have boosted the number of people driving vehicles, and hence the number of injuries has increased, which require surgical intervention. Embarrassment facilities provided by insurance companies attract potential consumers to opt for such services.
The European nations emerged as the next largest market for antithrombin due to the huge number of surgical procedures carried out in this region’s medical sector. Rapid advancements in the healthcare system that have been seen over time have boosted the demand for advanced technologies and antithrombin, which have better efficacy during surgical procedures. Better reimbursement facilities that have been provided encourage people to opt for advanced technologies and systems that prevent the number of casualties that take place on the operation table. The region of North America has also emerged as a major market for the growth of antithrombin.
Report Scope
| Feature of the Report | Details |
| Market Size in 2021 | USD 502.4 Million |
| Projected Market Size in 2030 | USD 735.12 Million |
| CAGR Growth Rate | 4.8% CAGR (2022-2030) |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Prominent Players | Lee Biosolutions, Scripps Laboratories, Octapharma AG, LFB USA, rEVO Biologics, Grifols, CSL Ltd, Kedrion, and Others |
| Key Segment | By Application Type, Source, Dosage, and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Key Players
- Lee Biosolutions
- Scripps Laboratories
- Octapharma AG
- LFB USA
- rEVO Biologics
- Grifols
- CSL Ltd
- Kedrion
Recent Developments
- In January 2013 – GTC biotherapeutics renewed its name and commitment to Revo biologics which will aim at transforming recombinant medicine.
Segments of the antithrombin market covered in the report
By Application Type
- Research
- Therapeutics
- Diagnostics
By Source
- Goat milk
- Human
By Dosage
- Liquid
- Lyophilized
On the basis of Geography
North America
- The U.S.
- Canada
- Mexico
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America